Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MSD MERCK CO

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 46
  • 0 comments

FDA approve POSACONAZOLE

Comment Full text

BARR

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 55
  • 0 comments

FDA approve ISONIAZID

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 53
  • 0 comments

FDA approve POSACONAZOLE

Comment Full text

BARR

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 51
  • 0 comments

FDA approve ISONIAZID

Comment Full text

NEXUS PHARMS

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 62
  • 0 comments

FDA approve MINOCYCLINE HYDROCHLORIDE

Comment Full text

XTTRIUM LABS INC

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 58
  • 0 comments

FDA approve AMANTADINE HYDROCHLORIDE

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 54
  • 0 comments

FDA approve FLUOXETINE HYDROCHLORIDE

Comment Full text

SHANDONG XINHUA

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 56
  • 0 comments

FDA approve SEVELAMER CARBONATE

Comment Full text

SCHERING

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 54
  • 0 comments

FDA approve POSACONAZOLE

Comment Full text

MERCK SHARP DOHME

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 42
  • 0 comments

FDA approve POSACONAZOLE

Comment Full text
  • Previous
  • 326
  • 327
  • 328
  • 329
  • 330
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158460)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin